Thorax Revisited is organized by United States and Canadian Academy of Pathology (USCAP) and will be held from Oct 23 - 24, 2025 at USCAP Interactive Center, Palm Springs, California, United States of America.
Course Description:
Accurate diagnosis of pleural disease is crucial to patient care. Pathologists are also increasingly asked to order and interpret molecular testing for lung carcinomas and other pulmonary tumors. Led by expert pathologists, this course will review common diagnostic pitfalls in thoracic pathology, cytology, and immunohistochemistry, along with new cases of mediastinal tumors, pleural tumors, and non-neoplastic lung disease. As molecular testing becomes more mainstream, interpreting these tests for lung carcinomas and other pulmonary tumors is of vital importance. Faculty will discuss issues related to molecular testing with a focus on what to order, when to order, and how to interpret the results. This course will feature lectures and interactive case-based discussions.
Learning Objectives:
Continuing Medical Education
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this live activity for a maximum of 16 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
USCAP is approved by the American Board of Pathology (ABPath) to offer Lifelong Learning credits for the purpose of meeting the ABPath requirements for Continuing Certification (CC).
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved